Drug Pipeline

Rifapentine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-19 NCT07595042 A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06253715 Shortened Regimen for Drug-susceptible TB in Children Tuberculosis Recruiting
Phase 2/3
NCT03474029 Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for… Latent Tuberculosis Recruiting
Phase 2
NCT07595042 A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) Tuberculosis Not Yet Recruiting
Phase 1/2
NCT07124559 A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in… Tuberculosis Not Yet Recruiting
Sponsors Running Rifapentine Trials
National Institute of Allergy and Infectious Diseases (NIAID) (2) Centers for Disease Control and Prevention (1) Johns Hopkins University (1)
Get alerts when Rifapentine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free